Research output per year
Research output per year
Personal profile
Biography
Dr. Regules (COL MC USA) is an infectious diseases physician and research leader for the US Army. His research encompasses clinical trials, malaria , biodefense, product development, international research, and vaccinology. Dr. Regules is currently the Director for the Foundational Sciences Directorate at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), an Associate Professor of Medicine at the USUHS, and affiliated staff at the Walter Reed National Military Medical Center. He is a Fellow of both the Infectious Diseases Society of America and the American College of Physicians.
Research interests
- Clinical Trials & Product Development
- Malaria Research
- Biodefense & Emerging Infectious Diseases –
- International Research & Global Health Security
- Vaccinology & Immunology
- Military Medicine & Readiness
Education/Academic qualification
Fellowship, Infectious Diseases, Brooke Army Medical Center
2005 → 2008
Internship and Residency, Internal Medicine, Brooke Army Medical Center
2002 → 2005
Doctor of Medicine, Uniformed Services University
1998 → 2002
Shasta College, Biology, General
1993 → 1995
University of California, Davis, Bachelor, Bachelor of Science, Neubiology,Psysiology and Behavior
Keywords
- R Medicine (General)
- Clinical Trials & Product Development
- Malaria Research
- Biodefense & Emerging Infectious Diseases
- International Research & Global Health Security
- Vaccinology & Immunology
- Military Medicine & Readiness
Fingerprint
Dive into the research topics where Jason A. Regules is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study
Hamer, M. J., McCarty, J. M., Pierson, B. C., Regules, J. A., Mendy, J., Sanborn, A. D., Gardner, C. L., Haller, J. M., Gregory, M. K., Liggett, D. L., Glass, P. J., Ghosh, N., Royalty Tredo, S., Warfield, K. L., Burke, C. W., Lee, C., Saunders, D., Bedell, L. & Richardson, J. S., Apr 2025, In: The Lancet Microbe. 6, 4, 101000.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A candidate antibody drug for prevention of malaria
Williams, K. L., Guerrero, S., Flores-Garcia, Y., Kim, D., Williamson, K. S., Siska, C., Smidt, P., Jepson, S. Z., Li, K., Dennison, S. M., Mathis-Torres, S., Chen, X., Wille-Reece, U., MacGill, R. S., Walker, M., Jongert, E., King, C. R., Ockenhouse, C., Glanville, J., Moon, J. E., & 10 others, Jan 2024, In: Nature Medicine. 30, 1, p. 117-129 13 p.Research output: Contribution to journal › Article › peer-review
21 Scopus citations -
Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein–Based Vaccine Adjuvanted With Glucopyranosyl Lipid A–Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge
Friedman-Klabanoff, D. A. J., Berry, A. A., Travassos, M. A., Shriver, M., Cox, C., Butts, J., Lundeen, J. S., Strauss, K. A., Joshi, S., Shrestha, B., Mo, A. X., Nomicos, E. Y. H., Deye, G. A., Regules, J. A., Bergmann-Leitner, E. S., Pasetti, M. F. & Laurens, M. B., 15 Jun 2024, In: Journal of Infectious Diseases. 229, 6, p. 1883-1893 11 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
EID-030 Study Group, Jun 2024, In: The Lancet Microbe. 5, 6, p. e581-e593Research output: Contribution to journal › Article › peer-review
Open Access28 Scopus citations -
Late-presenting Plasmodium falciparum Malaria in a Non-Endemic Setting During COVID-19 Travel Restrictions
Robben, P. M., Dunbar, C. R., Akin, E. H., Pichugin, A. & Regules, J. A., 1 May 2023, In: Military Medicine. 188, 5-6, p. e1335-e1337Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Press/Media
-
Study Findings from Walter Reed Army Institute of Research Provide New Insights into Liposomes [Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing ...]
Nelson L. Michael & Jason A. Regules
2/02/23
1 item of Media coverage
Press/Media
-
Malaria vaccine candidate safe and immunogenic following first-in-human trials
14/09/22
2 items of Media coverage
Press/Media
-
Malaria vaccine candidate safe and immunogenic following first-in-human trials
14/09/22
2 items of Media coverage
Press/Media
-
First-Ever Malaria Vaccine Has Roots in Army Medical Research
22/10/21
1 item of Media coverage
Press/Media
-
Monoclonal antibodies can be an effective tool in the global fight against malaria
8/03/21
2 items of Media coverage
Press/Media